- Report
- June 2020
- 111 Pages
Global
From €4564EUR$4,750USD£3,902GBP
- Report
- January 2022
- 60 Pages
Global
From €3795EUR$3,950USD£3,245GBP
- Report
- January 2022
- 200 Pages
Global
From €7206EUR$7,500USD£6,161GBP
- Report
- February 2020
- 166 Pages
North America
From €2018EUR$2,100USD£1,725GBP
€2883EUR$3,000USD£2,464GBP
- Report
- August 2022
Global
From €759EUR$790USD£649GBP
- Drug Pipelines
- June 2022
- 101 Pages
Global
From €10564EUR$10,995USD£9,032GBP
- Clinical Trials
- June 2020
- 205 Pages
Global
From €2402EUR$2,500USD£2,054GBP
- Drug Pipelines
- August 2020
- 86 Pages
Global
From €1922EUR$2,000USD£1,643GBP
- Report
- June 2023
- 141 Pages
China
From €1730EUR$1,800USD£1,479GBP
- Report
- June 2023
- 268 Pages
China
From €3843EUR$4,000USD£3,286GBP
- Report
- October 2023
- 112 Pages
Global
From €3500EUR$3,902USD£3,097GBP
- Report
- May 2023
- 81 Pages
Global
From €3500EUR$3,902USD£3,097GBP
- Report
- October 2023
- 112 Pages
Global
From €3500EUR$3,902USD£3,097GBP
- Report
- May 2023
- 91 Pages
Global
From €3500EUR$3,902USD£3,097GBP
- Report
- August 2022
- 51 Pages
Global
From €1922EUR$2,000USD£1,643GBP
- Drug Pipelines
- June 2021
- 92 Pages
Global
From €1922EUR$2,000USD£1,643GBP
- Drug Pipelines
- October 2020
- 47 Pages
Global
From €1922EUR$2,000USD£1,643GBP
- Report
- April 2023
- 147 Pages
Global
From €5764EUR$5,999USD£4,928GBP
- Report
- April 2023
- 147 Pages
Global
From €5764EUR$5,999USD£4,928GBP
The antiarrhythmic market is a subset of the cardiovascular drug market, which includes drugs used to treat abnormal heart rhythms. Antiarrhythmic drugs are used to treat arrhythmias, which are abnormal heart rhythms that can cause symptoms such as palpitations, dizziness, and chest pain. These drugs work by blocking or slowing down electrical signals in the heart, restoring the normal rhythm. Common types of antiarrhythmic drugs include beta blockers, calcium channel blockers, and potassium channel blockers.
The antiarrhythmic market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, Merck, Sanofi, Novartis, and GlaxoSmithKline. Other companies in the market include Bristol-Myers Squibb, AstraZeneca, and Boehringer Ingelheim. Show Less Read more